Today it was reported that the President & CEO of Catalyst Biosciences Inc (CBIO), USMAN NASSIM, exercised options to buy 4,400 CBIO shares at $4.63 a share, for a total transaction value of $20.37K.
Following this transaction USMAN NASSIM’s holding in the company was increased by 59.99% to a total of $132K. In addition to USMAN NASSIM, one other CBIO executive reported Buy trades in the last month.
See today’s analyst top recommended stocks >>
Currently, Catalyst Biosciences Inc has an average volume of 69.58K.
Starting in September 2018, CBIO received 10 Buy ratings in a row.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel medicines to address serious medical conditions. Its pipeline includes hemostasis such as Factor VIIa marzeptacog alfa, Factor IX dalcinonacog alfa, and Factor Xa; and anti-complement.
